| Product Code: ETC9513383 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Hemophilia B Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Hemophilia B Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Hemophilia B Market - Industry Life Cycle |
3.4 Suriname Hemophilia B Market - Porter's Five Forces |
3.5 Suriname Hemophilia B Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Suriname Hemophilia B Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Suriname Hemophilia B Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Suriname Hemophilia B Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Suriname Hemophilia B Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Hemophilia B Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about hemophilia B and its treatment options in Suriname |
4.2.2 Improved access to healthcare services and treatment facilities for hemophilia B patients |
4.2.3 Rising prevalence of hemophilia B in Suriname due to better diagnosis and healthcare infrastructure |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for hemophilia B treatment in Suriname |
4.3.2 High cost of hemophilia B treatment and medications, leading to affordability issues for patients |
4.3.3 Lack of government funding and support for hemophilia B treatment and research in Suriname |
5 Suriname Hemophilia B Market Trends |
6 Suriname Hemophilia B Market, By Types |
6.1 Suriname Hemophilia B Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Suriname Hemophilia B Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Suriname Hemophilia B Market Revenues & Volume, By Plasma Derived Coagulation Factor Concentrate, 2021- 2031F |
6.1.4 Suriname Hemophilia B Market Revenues & Volume, By Recombinant Coagulation Factor Concentrates, 2021- 2031F |
6.1.5 Suriname Hemophilia B Market Revenues & Volume, By Desmopressin, 2021- 2031F |
6.1.6 Suriname Hemophilia B Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Suriname Hemophilia B Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Suriname Hemophilia B Market Revenues & Volume, By On-Demand, 2021- 2031F |
6.2.3 Suriname Hemophilia B Market Revenues & Volume, By Prophylaxis, 2021- 2031F |
6.3 Suriname Hemophilia B Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Suriname Hemophilia B Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Suriname Hemophilia B Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4 Suriname Hemophilia B Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Suriname Hemophilia B Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Suriname Hemophilia B Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Suriname Hemophilia B Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Suriname Hemophilia B Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Suriname Hemophilia B Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Suriname Hemophilia B Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Suriname Hemophilia B Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Suriname Hemophilia B Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Suriname Hemophilia B Market Import-Export Trade Statistics |
7.1 Suriname Hemophilia B Market Export to Major Countries |
7.2 Suriname Hemophilia B Market Imports from Major Countries |
8 Suriname Hemophilia B Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for hemophilia B patients in Suriname |
8.2 Number of hemophilia B treatment centers and healthcare professionals in Suriname |
8.3 Patient adherence to treatment plans and therapy regimens for hemophilia B |
9 Suriname Hemophilia B Market - Opportunity Assessment |
9.1 Suriname Hemophilia B Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Suriname Hemophilia B Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Suriname Hemophilia B Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Suriname Hemophilia B Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Suriname Hemophilia B Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Hemophilia B Market - Competitive Landscape |
10.1 Suriname Hemophilia B Market Revenue Share, By Companies, 2024 |
10.2 Suriname Hemophilia B Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here